Literature DB >> 33776745

Cerebellar Calcium-Binding Protein and Neurotrophin Receptor Defects in Down Syndrome and Alzheimer's Disease.

Jennifer C Miguel1, Sylvia E Perez1, Michael Malek-Ahmadi2, Elliott J Mufson1,3.   

Abstract

Cerebellar hypoplasia is a major characteristic of the Down syndrome (DS) brain. However, the consequences of trisomy upon cerebellar Purkinje cells (PC) and interneurons in DS are unclear. The present study performed a quantitative and qualitative analysis of cerebellar neurons immunostained with antibodies against calbindin D-28k (Calb), parvalbumin (Parv), and calretinin (Calr), phosphorylated and non-phosphorylated intermediate neurofilaments (SMI-34 and SMI-32), and high (TrkA) and low (p75NTR) affinity nerve growth factor (NGF) receptors as well as tau and amyloid in DS (n = 12), Alzheimer's disease (AD) (n = 10), and healthy non-dementia control (HC) (n = 8) cases. Our findings revealed higher Aβ42 plaque load in DS compared to AD and HC but no differences in APP/Aβ plaque load between HC, AD, and DS. The cerebellar cortex neither displayed Aβ40 containing plaques nor pathologic phosphorylated tau in any of the cases examined. The number and optical density (OD) measurements of Calb immunoreactive (-ir) PC soma and dendrites were similar between groups, while the number of PCs positive for Parv and SMI-32 were significantly reduced in AD and DS compared to HC. By contrast, the number of SMI-34-ir PC dystrophic axonal swellings, termed torpedoes, was significantly greater in AD compared to DS. No differences in SMI-32- and Parv-ir PC OD measurements were observed between groups. Conversely, total number of Parv- (stellate/basket) and Calr (Lugaro, brush, and Golgi)-positive interneurons were significantly reduced in DS compared to AD and HC. A strong negative correlation was found between counts for Parv-ir interneurons, Calr-ir Golgi and brush cells, and Aβ42 plaque load. Number of TrkA and p75NTR positive PCs were reduced in AD compared to HC. These findings suggest that disturbances in calcium binding proteins play a critical role in cerebellar neuronal dysfunction in adults with DS.
Copyright © 2021 Miguel, Perez, Malek-Ahmadi and Mufson.

Entities:  

Keywords:  Alzheimer's disease; Down syndrome; Purkinje cells; amyloid; calcium binding proteins; cerebellum; nerve growth factor receptors; tau

Year:  2021        PMID: 33776745      PMCID: PMC7994928          DOI: 10.3389/fnagi.2021.645334

Source DB:  PubMed          Journal:  Front Aging Neurosci        ISSN: 1663-4365            Impact factor:   5.750


  174 in total

Review 1.  [Structure and function of the cerebellum].

Authors:  J M Delgado-García
Journal:  Rev Neurol       Date:  2001 Oct 1-15       Impact factor: 0.870

2.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

3.  Dementia diagnostic criteria in Down syndrome.

Authors:  Rory Sheehan; Amanda Sinai; Nick Bass; Pippa Blatchford; Ingrid Bohnen; Simon Bonell; Ken Courtenay; Angela Hassiotis; Therese Markar; Jane McCarthy; Kamalika Mukherji; Asim Naeem; Dimitrios Paschos; Natalia Perez-Achiaga; Vijaya Sharma; David Thomas; Zuzana Walker; Andre Strydom
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

4.  Neurobiology: a move to sort life from death.

Authors:  David R Kaplan; Freda D Miller
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

5.  Alzheimer's disease and the cerebellum: a morphologic study on neuronal and glial changes.

Authors:  M Sjöbeck; E Englund
Journal:  Dement Geriatr Cogn Disord       Date:  2001 May-Jun       Impact factor: 2.959

Review 6.  Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.

Authors:  Dietmar Rudolf Thal; Jochen Walter; Takaomi C Saido; Marcus Fändrich
Journal:  Acta Neuropathol       Date:  2014-12-23       Impact factor: 17.088

7.  Purkinje Cells Pathology in Alzheimer's Disease.

Authors:  Ioannis Mavroudis; Foivos Petridis; Dimitrios Kazis; Samuel N Njau; Vasiliki Costa; Stavros J Baloyannis
Journal:  Am J Alzheimers Dis Other Demen       Date:  2019-06-30       Impact factor: 2.035

8.  Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.

Authors:  S M de la Monte; E T Hedley-Whyte
Journal:  J Neuropathol Exp Neurol       Date:  1990-09       Impact factor: 3.685

Review 9.  Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease.

Authors:  John H Morrison; Patrick R Hof
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

Review 10.  Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease.

Authors:  Wook Jin
Journal:  J Clin Med       Date:  2020-01-17       Impact factor: 4.241

View more
  3 in total

1.  Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer's Disease and Down Syndrome.

Authors:  Simona Capsoni; Antonino Cattaneo
Journal:  Front Neurosci       Date:  2022-03-09       Impact factor: 4.677

2.  Upregulated Ca2+ Release from the Endoplasmic Reticulum Leads to Impaired Presynaptic Function in Familial Alzheimer's Disease.

Authors:  Temitope Adeoye; Syed I Shah; Angelo Demuro; David A Rabson; Ghanim Ullah
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

3.  Alzheimer's-like signaling in brains of COVID-19 patients.

Authors:  Steve Reiken; Leah Sittenfeld; Haikel Dridi; Yang Liu; Xiaoping Liu; Andrew R Marks
Journal:  Alzheimers Dement       Date:  2022-02-03       Impact factor: 21.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.